Clinical Trials Logo

Meningomyelocele clinical trials

View clinical trials related to Meningomyelocele.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05711355 Completed - Clinical trials for Meningomyelocele/Spina Bifida

the Effects of Platelet-Rich Plasma on Postoperative Complications After Meningomyelocele

Start date: January 15, 2022
Phase: N/A
Study type: Interventional

Introduction: Meningomyelocele is a common congenital neural tube defect. To reduce complications, early surgery and a multidisciplinary approach is needed. In this study, the investigators administered platelet-rich plasma (PRP) to newborns with meningomyelocele following corrective surgery to minimize cerebrospinal fluid (CSF) leakage and accelerate the healing of the immature pouch tissue. The investigators compared these with a control group that did not receive PRP. Patients and Methods: Of the 40 newborns who were operated on with the diagnosis of meningomyelocele, 20 patients received PRP after surgical repair, and 20 were followed up without PRP. In the PRP group, 10 of the 20 patients underwent primary defect repair, the other 10 underwent flap repair. In the group that did not receive PRP, primary closure was performed in 14 patients and flap closure in six.

NCT ID: NCT05188300 Completed - Meningomyelocele Clinical Trials

Propellers Flaps for Meningomylocele Defects

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

To evaluate reliability of free style propeller perforator flap for coverage MMC soft tissue defect follow a well-established step that overcome the usual problem of pedicled perforators propellers flaps.

NCT ID: NCT04468568 Completed - Myelomeningocele Clinical Trials

In Utero Repair of Myelomeningocele: Atosiban Versus Terbutaline

Start date: October 1, 2017
Phase:
Study type: Observational

Myelomeningocele is a malformation with high incidence, and it consists in a neural tube defect. Fetal intrauterine surgery is an alternative for correction, and it improves the prognosis of the fetus, but has an increased risk of maternal complications and premature labor, as it can occur due to uterine stimulation. It is therefore essential that tocolysis is performed before, during and after surgery, and the most commonly used tocolytics are terbutaline and atosiban. Terbutaline has no specificity and may have several adverse effects such as maternal acidosis.

NCT ID: NCT04356703 Completed - Myelomeningocele Clinical Trials

Fetoscopic Open Spina Bifida Repair Using the SAFER Technique

Start date: April 1, 2017
Phase:
Study type: Observational

Children submitted to fetoscopic in utero myelomeningocele repair using the SAFER (Skin-over-biocellulose for Anternatal FEtoscopic Repair) technique will evaluate at 30 months or more, regarding ambulation, neurodevelopment, urinary and fecal status.

NCT ID: NCT04187027 Completed - Neurogenic Bladder Clinical Trials

Efficacy Of Pulsed Electromagnetic Field Therapy On Neurogenic Bladder in Children With Myelomeningocele

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

This study was conducted to assess the efficacy of pulsed electromagnetic field therapy on neurogenic bladder in children with myelomeningocele .Intervention: A pretest-post test controlled study was conducted in out-patient clinic in faculty of physical therapy Cairo university.

NCT ID: NCT04186338 Completed - Physical Activity Clinical Trials

Daily Physical Activity in Myelomeningocele

Start date: December 1, 2016
Phase:
Study type: Observational

Obesity is getting more common and challenging to treat in children and adolescents with myelomeningocele. Therefore, it is becoming more important to determine daily physical activity in these patients. Daily walking performance and average steps per day in patients with low lumbar and sacral level myelomeningocele are shown to not differ from healthy controls. Step counts can not reflect all torsional accelerations associated with daily living activities. Omnidirectional accelerometers provide all types of body movement outputs and give detailed parameters of physical activity level and energy expenditure. There is no data about energy expenditure and physical activity level of the patients with myelomeningocele in daily routine. This study aims to quantify energy expenditure and physical activity of children and adolescents with low lumbar and sacral level myelomeningocele.

NCT ID: NCT04027374 Completed - Meningomyelocele Clinical Trials

Stress-associated Epigenetic Alterations in Newborns After Fetal Surgery

Start date: July 1, 2019
Phase:
Study type: Observational

Open spina bifida or myelomeningocele (MMC) is a devastating congenital defect of the central nervous system for which there is no cure. The etiology of MMC remains poorly understood. Primary failure of neural tube closure at the caudal neuropore in the embryonic period results in exposure of the developing spinal cord to the uterine environment. Without protective tissue coverage, secondary destruction of the exposed neural tissue by trauma or amniotic fluid may occur throughout gestation. In order to protect the spinal cord from this secondary destruction, a fetal surgical repair can be performed between gestational weeks 20 and 26. From a psychological point of view fetal repair of MMC constitutes a highly stressful event both for the mother and the fetus. To date, however, stress of mothers and children in case of prenatal surgery for MMC repair has never been studied. It is therefore unclear, if and to what extend the procedure and its consequences are associated with stress, and if there are short- or longer-term consequences. The aims of this study are threefold: 1. Do newborns after fetal surgery for MMC show epigenetic alterations in genes that are involved in stress regulation? 2. With which medical and psychosocial variables are epigenetic alterations associated? 3. At age 3 months, do infants after fetal surgery have a more difficult temperament compared to controls?

NCT ID: NCT03550898 Completed - Neurogenic Bladder Clinical Trials

Can Dynamic Ultrasonography Replace Urodynamics in Follow-up of Patients With Myelomeningocele

Start date: June 1, 2014
Phase: N/A
Study type: Interventional

Patients with neurogenic bladder need periodic evaluation with urodynamic study, a invasive and uncomfortable procedure. Aim: To evaluate the accuracy of dynamic ultrasonography as a feasible and noninvasive alternative diagnostic method to identify detrusor overactivity in patients with neurogenic bladder

NCT ID: NCT03073382 Completed - Myelomeningocele Clinical Trials

Risk Factors Associated With Spontaneous Preterm Delivery Status Post Open Fetal Myelomeningocele Repair

Start date: January 1, 2017
Phase:
Study type: Observational

This is a chart review of all patients who have underwent open prenatal repair of fetal myelomeningocele. Although prenatal repair is associated with improved neurologic outcomes and a decreased need for cerebrospinal fluid shunting after birth, one of the major risks is preterm delivery. This study is intended to identify maternal, fetal or intraoperative risk factors associated with preterm delivery.

NCT ID: NCT02595411 Completed - Stroke Clinical Trials

Reliability of the Melbourne Assessment

Start date: July 2015
Phase: N/A
Study type: Observational

The aim of the study is to investigate the reliability of the Melbourne Assessment.